N-Succinimidyl 4-formylbenzoate, 98%

Name: N-Succinimidyl 4-formylbenzoate, 98% | 60444-78-2
Brand: J&K Chemical
SKU: JK440927_100_MG
Price: 9.12 USD
Availability: InStock

Cat. No JK440927_100_MG

Vendor: J&K Chemical

Product Information

Product Name

N-Succinimidyl 4-formylbenzoate, 98%

Brand Name

J&K

Product Number

440927

CAS

60444-78-2

Molecular Formula

C12H9NO5

Molecular Weight

247.20

SDS Document

View/Download

Certificate of Analysis (COA)

COA not found

General Information

Synonyms

4-Formylbenzoic Acid N-Succinimidyl Ester

PubChem CID

4126130

IUPAC Name

(2,5-dioxopyrrolidin-1-yl) 4-formylbenzoate

InChI Key

VHYRHFNOWKMCHQ-UHFFFAOYSA-N

SMILES

C1CC(=O)N(C1=O)OC(=O)C2=CC=C(C=C2)C=O

Properties

Melting Point

168-175

Safety Information

Precautionary Statement

P262

Storage Condition

Store at 2-8℃

References Data Source From Pubchem

Synthesis and in vivo evaluation of 18F-cPNA and Dendrimer-PNA conjugate for amplification pretargeting

Publication Name: Journal of Radioanalytical and Nuclear Chemistry

Publication Date: 2022-05-06

DOI: 10.1007/s10967-022-08289-y

Highly multiplexed profiling of cell surface proteins on single circulating tumor cells based on antibody and cellular barcoding

Publication Name: Analytical and Bioanalytical Chemistry

Publication Date: 2019-02-28

DOI: 10.1007/s00216-019-01666-9

Probing the Platinum(IV) Prodrug Hypothesis. Are Platinum(IV) Complexes Really Prodrugs of Cisplatin?

Publication Name: Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches

Publication Date: 2018

DOI: 10.1007/978-981-10-8594-9_3

Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents

Publication Name: Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches

Publication Date: 2018

DOI: 10.1007/978-981-10-8594-9_5

Magnetic Resonance Spectroscopy of siRNA-Based Cancer Therapy

Publication Name: Methods in molecular biology (Clifton, N.J.)

Publication Date: 2016

DOI: 10.1007/978-1-4939-3148-4_3

N-Succinimidyl 4-formylbenzoate, 98%

Product Information

General Information

Properties

Safety Information

References Data Source From Pubchem

Synthesis and in vivo evaluation of 18F-cPNA and Dendrimer-PNA conjugate for amplification pretargeting

Highly multiplexed profiling of cell surface proteins on single circulating tumor cells based on antibody and cellular barcoding

Probing the Platinum(IV) Prodrug Hypothesis. Are Platinum(IV) Complexes Really Prodrugs of Cisplatin?

Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents

Magnetic Resonance Spectroscopy of siRNA-Based Cancer Therapy